Cargando…
Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
Autores principales: | Li, Jia-Yi, Lu, Yong-Hong, Zhang, Li-Wen, Zhou, Pei-Mei, Chen, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318513/ https://www.ncbi.nlm.nih.gov/pubmed/28223765 http://dx.doi.org/10.5021/ad.2017.29.1.121 |
Ejemplares similares
-
High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005) -
Increased Serum Concentrations of High Mobility Group Box 1 (HMGB1) Protein in Children with Autism Spectrum Disorder
por: Makris, Gerasimos, et al.
Publicado: (2021) -
The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells
por: Ostrand-Rosenberg, Suzanne, et al.
Publicado: (2023) -
The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014) -
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
por: Abdulahad, Deena A, et al.
Publicado: (2011)